Atrial Fibrillation, Ventricular Arrhythmia, and Left Ventricular Remodeling in the ICU – First Results of the Single- Center RHYTHM-ACC Registry

1. Azevedo PS, Polegato BF, Minicucci MF, Paiva SA, Zornoff LA. Cardiac Remodeling: Concepts. Clinical Impact. Pathophysiological Mechanisms and Pharmacologic Treatment. Arq Bras Cardiol. 2016;106:62-69. doi: 10.5935/abc.20160005.Search in Google Scholar

2. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000;35:569-582.10.1016/S0735-1097(99)00630-0Search in Google Scholar

3. Anand IS, Florea VG, Solomon SD, Konstam MA, Udelson JE. Noninvasive assessment of left ventricular remodeling: concepts, techniques, and implications for clinical trials. J Card Fail. 2002;8:S452-64. doi: 10.1054/jcaf.2002.129286.Search in Google Scholar

4. Liu L, Eisen HJ. Epidemiology of heart failure and scope of the problem. Cardiol Clin. 2014;32:1-8,vii. doi: 10.1016/j.ccl.2013.09.009.Search in Google Scholar

5. Pimentel M, Zimerman LI, Rohde LE. Stratification of the risk of sudden death in nonischemic heart failure. Arq Bras Cardiol. 2014;103:348-357. doi: 10.5935/abc.20140125.Search in Google Scholar

6. Braunwald E. Heart failure. JACC Heart Fail. 2013;1:1-20. doi: 10.1016/j.jchf.2012.10.002.Search in Google Scholar

7. Suthahar N, Meijers WC, Silljé HHW, de Boer RA. From Inflammation to Fibrosis - Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities. Curr Heart Fail Rep. 2017;14:235-250. doi: 10.1007/s11897-017-0343-y.Search in Google Scholar

8. Yndestad A, Damås JK, Oie E, Ueland T, Gullestad L, Aukrust P. Systemic inflammation in heart failure-the whys and wherefores. Heart Fail Rev. 2006;11:83-92. doi: 10.1007/s10741-006-9196-2.Search in Google Scholar

9. Heymans S, Hirsch E, Anker SD, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009;11:119-129. doi: 10.1093/eurjhf/hfn043.Search in Google Scholar

10. Dick SA, Epelman S. Chronic heart failure and inflammation: what do we really know? Circ Res. 2016;119:159-176. doi: 10.1161/CIRCRESAHA.116.308030.Search in Google Scholar

11. Grieve DJ, Shah AM. Oxidative stress in heart failure: More than just damage. Eur Heart J. 2003;24:2161-2163. doi: https://doi.org/10.1016/j.ehj.2003.10.015.Search in Google Scholar

12. de Jong S, van Veen TA, de Bakker JM, Vos MA, van Rijen HV. Biomarkers of myocardial fibrosis. J Cardiovasc Pharmacol. 2011;57:522-535. doi: 10.1097/FJC.0b013e31821823d9.Search in Google Scholar

13. Kotecha D, Piccini JP. Atrial fibrillation in heart failure: what should we do? Eur Heart J. 2015;36:3250-3257. doi: 10.1093/eurheartj/ehv513.Search in Google Scholar

14. Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009;119:2516-2525. doi: 10.1161/CIRCULATIONAHA.108.821306.Search in Google Scholar

15. Lee Park K, Anter E. Atrial Fibrillation and Heart Failure: A Review of the Intersection of Two Cardiac Epidemics. J Atr Fibrillation. 2013;6:751. doi: 10.4022/jafib.751.Search in Google Scholar

16. Kalifa J, Jalife J, Zaitsev AV, et al. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation. 2003;108:668-671. doi: 10.1161/01.CIR.0000086979.39843.7B.Search in Google Scholar

17. Lalani GG, Schricker A, Gibson M, Rostamian A, Krummen DE, Narayan SM. Atrial conduction slows immediately before the onset of human atrial fibrillation: a bi-atrial contact mapping study of transitions to atrial fibrillation. J Am Coll Cardiol. 2012;59:595-606. doi: 10.1016/j.jacc.2011.10.879.Search in Google Scholar

18. Mills RW, Narayan SM, McCulloch AD. Mechanisms of conduction slowing during myocardial stretch by ventricular volume loading in the rabbit. Am J Physiol Heart Circ Physiol. 2008;295:H1270-H1278. doi: 10.1152/ajpheart.00350.2008.Search in Google Scholar

19. Stiles MK, John B, Wong CX, et al. Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the ‘second factor’. J Am Coll Cardiol. 2009;53:1182-1191. doi: 10.1016/j.jacc.2008.11.054.Search in Google Scholar

20. Healey JS, Israel CW, Connolly SJ, et al. Relevance of electrical remodeling in human atrial fibrillation: results of the asymptomatic atrial fibrillation and stroke evaluation in pacemaker patients and the atrial fibrillation reduction atrial pacing trial mechanisms of atrial fibrillation study. Circ Arrhythm Electrophysiol. 2012;5:626-631. doi: 10.1161/CIRCEP.112.970442.Search in Google Scholar

21. Kareti KR, Chiong JR, Hsu SS, Miller AB. Congestive heart failure and atrial fibrillation: rhythm versus rate control. J Card Fail. 2005;11:164-172. https://doi.org/10.1016/j.cardfail.2004.09.011.10.1016/j.cardfail.2004.09.011Open DOISearch in Google Scholar

22. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91:2D-8D.10.1016/S0002-9149(02)03373-8Search in Google Scholar

23. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108. doi: 10.1016/j.euje.2005.12.014.Search in Google Scholar

24. Pedersen CT, Kay GN, Kalman J, et al. ESC Scientific Document Group; EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. EP Europace. 2014;16:1257-1283. doi: https://doi.org/10.1093/europace/euu194.Search in Google Scholar

25. Katritsis DG, Camm AJ. Nonsustained ventricular tachycardia: where do we stand? Eur Heart J. 2004;15:1093-1099. doi: 10.15420/aer.2016:5.3.GL1.Search in Google Scholar

26. Hadid C. Sustained ventricular tachycardia in structural heart disease. Cardiol J. 2015;22:12-24. doi: 10.5603/CJ.a2014.0069.Search in Google Scholar

27. Katritsis DG, Zareba W, Camm AJ. Nonsustained Ventricular Tachycardia. J Am Coll Cardiol. 2012;60:1993-2004. doi: 10.1016/j.jacc.2011.12.063.Search in Google Scholar

28. Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;125:1043-1052. doi: 10.1161/CIRCULATIONAHA.111.023846.Search in Google Scholar

29. Benito B, Josephson ME. Ventricular tachycardia in coronary artery disease. Rev Esp Cardiol (Engl Ed). 2012;65:939-955. doi: 10.1016/j.recesp.2012.03.027.Search in Google Scholar

30. Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. Lancet. 2017;390:400-414. doi: 10.1016/S0140-6736(16)31713-5.Search in Google Scholar

31. Merlo M, Cannatà A, Gobbo M, Stolfo D, Elliott PM, Sinagra G. Evolving concepts in dilated cardiomyopathy. Eur J Heart Fail. 2018;20:228-239. doi: 10.1002/ejhf.1103.Search in Google Scholar

32. Mazur A, Kusniec J, Strasberg B. Bundle branch reentrant ventricular tachycardia. Indian Pacing Electrophysiol J. 2005;5:86-95.Search in Google Scholar

33. Hodkinson EC, Aston K, Walsh SJ. Left bundle branch block morphology ventricular tachycardia in a marathon runner. Ulster Med J. 2012;81:130-133.Search in Google Scholar

34. Gorenek B, Cengiz O, Kudaiberdieva G, et al. Mode of onset of polymorphic ventricular tachycardia in acute myocardial infarction. Can J Cardiol. 2010;26:e254-257.10.1016/S0828-282X(10)70421-9Search in Google Scholar

35. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119-177. https://doi.org/10.1093/eurheartj/ehx393.10.1093/eurheartj/ehx39328886621Open DOISearch in Google Scholar

36. Blomstrom-Lundqvist C, Mazzanti A, Blom N, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Eur Heart J. 2015;36:2793-2867. doi: 10.1093/eurheartj/ehv316.Search in Google Scholar

37. Ellis ER, Josephson ME. What About Tachycardia-induced Cardiomyopathy? Arrhythm Electrophysiol Rev. 2013;2:82-90. doi: 10.15420/aer.2013.2.2.82.Search in Google Scholar

38. Elliot P. Defining Tachycardia-Induced Cardiomyopathy. J Am Coll Cardiol. 2017;69:2173-2174. doi: 10.1016/j.jacc.2017.03.536.Search in Google Scholar

39. Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological Mechanisms of Atrial Fibrillation: A Translational Appraisal. Physiol Rev. 2011;91:265-325. doi: 10.1152/physrev.00031.2009.Search in Google Scholar

40. Ulus T, Kudaiberdieva G, Gorenek B. The onset mechanisms of ventricular tachycardia. Int J Cardiol. 2013;167:619-623. doi: 10.1016/j.ijcard.2012.09.034.Search in Google Scholar

41. López Gil M, Arribas F, Cosío FG. Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy. Europace. 2000;2:327-332. https://doi.org/10.1053/eupc.2000.0117.10.1053/eupc.2000.011711194600Open DOISearch in Google Scholar

42. Link MS, Bockstall K, Weinstock J, et al. Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications. J Cardiovasc Electrophysiol. 2017;28:531-537. doi: 10.1111/jce.13194.Search in Google Scholar

43. Espinoza CA, Mehra S, DeAntonio H. Double Trouble: Concurrent Atrial Fibrillation and Ventricular Tachycardia. Rev Esp Cardiol (Engl Ed). 2016;69:779-780. doi: 10.1016/j. rec.2015.12.026Search in Google Scholar

44. Osman F, Ward R, Morley-Davies A. Simultaneous spontaneous onset of ventricular tachycardia and termination of atrial fibrillation. Europace. 2008;10:171-172. doi: 10.1093/europace/eum294.Search in Google Scholar

45. Boriani G, Rapezzi C, Biffi M, Branzi A, Spirito P. Atrial fibrillation precipitating sustained ventricular tachycardia in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol.2002;13:954.10.1046/j.1540-8167.2002.00954.x12380941Search in Google Scholar